Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Novavax Inc.

NAS: NVAX

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Novavax Inc.

Before the Bell

NVAX
/zigman2/quotes/202614340/composite

$

75.85

Change

-3.62 -4.56%

Volume

Volume 1,259

Jan 25, 2022, 4:08 a.m.

Real time quotes

/zigman2/quotes/202614340/composite

Previous close

$ 79.47

$ 79.47

Change

-5.18 -6.12%

Day low

Day high

$66.38

$81.12

Open
Open: 81.12

52 week low

52 week high

$66.38

$331.68

Open

Market cap

$6.40B

Average volume

6.16M

P/E ratio

N/A

Rev. per Employee

$1.52M

EPS

-14.82

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nvax

MarketWatch News on NVAX

  1. Citi Asks London Staff to Return to Office 3 Days a Week

    7:59 a.m. Jan. 20, 2022

    - Lina Saigol

  4. Sanofi CEO Says Vaccine Incumbents Are Set to Win

    4:00 a.m. Jan. 17, 2022

    - Josh Nathan-Kazis

  5. The Dow Dropped. Investors Didn't Love Big Banks' Earnings.

    4:27 p.m. Jan. 14, 2022

    - Jacob Sonenshine

  9. Novavax' COVID-19 vaccine wins approval in South Korea

    6:10 a.m. Jan. 12, 2022

    - Ciara Linnane

  11. Novavax granted approval for COVID-19 vaccine in South Korea

    6:03 a.m. Jan. 12, 2022

    - Ciara Linnane

  19. FDA Signs Off on Boosters for Younger Teens

    4:21 p.m. Jan. 3, 2022

    - Josh Nathan-Kazis

  20. Moderna and Other Vaccine Stocks Struggle to Shake Slump

    10:52 a.m. Dec. 29, 2021

    - Sabrina Escobar

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nvax

Other News on NVAX

  1. New York judge blocks statewide mask mandate - Reuters

    54 min ago

    - Seeking Alpha

  4. Novavax: No Wind In The Sails

    12:00 p.m. Jan. 24, 2022

    - Seeking Alpha

  5. Where Will BioNTech Be in 3 Years?

    7:00 a.m. Jan. 24, 2022

    - Motley Fool

  6. 1 Green Flag for Novavax in 2022, and 1 Red Flag

    6:00 a.m. Jan. 23, 2022

    - Motley Fool

  7. How the future for COVID-19 boosters could impact vaccine names

    4:00 p.m. Jan. 22, 2022

    - Seeking Alpha

  8. The Worst Mistake Moderna Investors Can Make in 2022

    6:00 a.m. Jan. 22, 2022

    - Motley Fool

  10. 2 Growth Stocks That Could Take Off in February

    11:15 a.m. Jan. 21, 2022

    - Motley Fool

  12. Why Novavax Stock Tumbled on Thursday

    5:35 p.m. Jan. 20, 2022

    - Motley Fool

  15. Novavax's Long-Term Prospects Are Questionable

    8:57 a.m. Jan. 20, 2022

    - Seeking Alpha

  17. Novavax COVID-19 vaccine cleared in Australia

    6:50 a.m. Jan. 20, 2022

    - Seeking Alpha

  19. Could Novavax Go Parabolic?

    6:30 a.m. Jan. 19, 2022

    - Motley Fool

  20. The Right Bet On BioNTech SE

    4:37 p.m. Jan. 18, 2022

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/nvax

Press Releases on NVAX

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.